OBJECTIVES/GOALS: Decoding the origins of cell-free DNA (cfDNA) released from dying
cells in a liquid biopsy sample (eg blood) offers the potential to provide insight into the …

OBJECTIVES/GOALS: Decoding the origins of cell-free DNA (cfDNA) released from dying
cells in a liquid biopsy sample (eg blood) can provide insight into the dynamic, organism …

In recent years, the rapid development of next-generation sequencing (NGS) has led to a
significant increase in accuracy toward molecular profiling, allowing noninvasive and real …

The heterogeneity of each individual oncologic disease can be mirrored by molecular
analysis of a simple blood draw in real time. Liquid biopsy testing has been shown useable …

This review provides a comprehensive overview of the latest advancements in the clinical
utility of liquid biopsy, with a particular focus on epigenetic approaches aimed at overcoming …

We discuss a recent manuscript providing recommendations to improve use and access for
liquid biopsy in oncology.

Historically, studies of disseminated tumour cells in bone marrow and circulating tumour
cells in peripheral blood have provided crucial insights into cancer biology and the …

Liquid biopsies have emerged as a promising and minimally invasive alternative to
traditional tissue biopsies for detecting and monitoring cancer. Liquid biopsies offer a …

Precision medicine aims to characterize the unique molecular profile of individual tumors in
order to predict clinical course and inform therapeutic decisions. The success of this …

Liquid biopsies are emerging as powerful minimally invasive approaches that have the
potential to solve several long-standing problems spanning the continuum of cancer care …